These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 497542)

  • 1. The cellular mechanism of action of nimodipine (BAY e 9736), a new calcium antagonist [proceedings].
    Towart R; Kazda S
    Br J Pharmacol; 1979 Nov; 67(3):409P-410P. PubMed ID: 497542
    [No Abstract]   [Full Text] [Related]  

  • 2. Nimodipine inhibits carbocyclic thromboxane-induced contractions of cerebral arteries.
    Towart R; Perzborn E
    Eur J Pharmacol; 1981 Jan; 69(2):213-5. PubMed ID: 7202520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium-antagonistic dihydropyridines. An investigation of the mechanism of action of nimodipine.
    Towart R
    Circ Res; 1981 May; 48(5):650-7. PubMed ID: 7214673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle.
    Towart R; Wehinger E; Meyer H; Kazda S
    Arzneimittelforschung; 1982; 32(4):338-46. PubMed ID: 7201802
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of nimodipine (Bay e 9736) on cerebral circulation in cats.
    Tanaka K; Gotoh F; Muramatsu F; Fukuuchi Y; Amano T; Okayasu H; Suzuki N
    Arzneimittelforschung; 1980; 30(9):1494-7. PubMed ID: 7193015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].
    Fleckenstein A; Tritthart H; Döring HJ; Byon KY
    Arzneimittelforschung; 1972 Jan; 22(1):22-33. PubMed ID: 4259147
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].
    Grün G; Fleckenstein A
    Arzneimittelforschung; 1972 Feb; 22(2):334-44. PubMed ID: 4623697
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of nimodipine, a calcium antagonist with preferential cerebrovascular activity.
    Kazda S
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():70-3. PubMed ID: 4010868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioassay of vasoactive drugs using isolated perfused rabbit arteries.
    Van Nueten JM
    Eur J Pharmacol; 1969; 6(3):286-93. PubMed ID: 5799190
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium channel antagonist binding sites labeled by 3H-nimodipine in human brain.
    Peroutka SJ; Allen GS
    J Neurosurg; 1983 Dec; 59(6):933-7. PubMed ID: 6631515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nimodipine on cerebral blood flow.
    Haws CW; Gourley JK; Heistad DD
    J Pharmacol Exp Ther; 1983 Apr; 225(1):24-8. PubMed ID: 6834275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of extracellular calcium and of calcium antagonists on the contractile responses of isolated human pial and mesenteric arteries.
    Brandt L; Andersson KE; Edvinsson L; Ljunggren B
    J Cereb Blood Flow Metab; 1981; 1(3):339-47. PubMed ID: 6948814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay e 9736).
    Nordström O; Braesch-Andersen S; Bartfai T
    Acta Physiol Scand; 1986 Jan; 126(1):115-9. PubMed ID: 3953299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
    Satoh K; Kawada M; Wada Y; Taira N
    Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the choline esters of substituted pyridinecarboxylic, aminobenzoic and nitrobenzoic acids.
    Kosersky DS; Malone MH; Adams JG
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):443-50. PubMed ID: 5715415
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
    O'Neill SK; McKay DW; Campbell N; Triggle CR; Crowley M; Bolger GT
    J Pharmacol Exp Ther; 1990 Jun; 253(3):905-12. PubMed ID: 1694243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of calcium antagonists PN 200-110, nifedipine, and nimodipine on human and canine cerebral arteries.
    Müller-Schweinitzer E; Neumann P
    J Cereb Blood Flow Metab; 1983 Sep; 3(3):354-61. PubMed ID: 6223932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats.
    Tanaka K; Gotoh F; Muramatsu F; Fukuuchi Y; Okayasu H; Suzuki N; Kobari M
    Arzneimittelforschung; 1982; 32(12):1529-34. PubMed ID: 6891592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contractions of the canine coronary artery in calcium-free solution.
    Rooke TW; Rimele TJ; Vanhoutte PM
    Am J Physiol; 1984 Aug; 247(2 Pt 2):H259-63. PubMed ID: 6589964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NS-398 (a selective cyclooxygenase-2 inhibitor) decreases agonist-induced contraction of the human ureter via calcium channel inhibition.
    Lee SY; Lee MY; Park SH; Kim TH; Moon YT; Han JH; Myung SC
    J Endourol; 2010 Nov; 24(11):1863-8. PubMed ID: 20958135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.